EMEA-000463-PIP02-10 - paediatric investigation plan
imatinib mesilate
PIPHuman
Novartis Europharm Limited
paediatric.enquiries@novartis.com
Phone: +41 61 324 1111
Fax: +41 61 324 8001
P/85/2011: EMA decision of 8 April 2011 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for imatinib (mesilate) (Glivec) (EMEA-000463-PIP02-10)